Sign in
4

Changes in Ownership

Atara Biotherapeutics, Inc. Filed Acc 0001209191-18-021844

Chief Executive Officer sold 8,800 shares at an average $38.59 ($339,549)

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
Ciechanover Isaac E. Chief Executive Officer 2018-03-26 Sale −3,200 $39.72 $127,104 212,078 I: show line 1 in the form
Ciechanover Isaac E. Chief Executive Officer 2018-03-26 Sale −1,200 $41.12 $49,344 210,878 I: show line 2 in the form
Ciechanover Isaac E. Chief Executive Officer 2018-03-27 Sale −2,700 $36.63 $98,901 208,178 I: show line 3 in the form
Ciechanover Isaac E. Chief Executive Officer 2018-03-27 Sale −1,500 $37.68 $56,520 206,678 I: show line 4 in the form
Ciechanover Isaac E. Chief Executive Officer 2018-03-27 Sale −200 $38.40 $7,680 206,478 D: show line 5 in the form
Open-market sales · 8,800 sh · avg $38.59 · $339,549
Loading xslF345X03/doc4.xml…